Athena capital: BioNTech Raises $325m Series B financing led by Fidelity Management & Research Company

Talent4Boards - Great Talent builds Great Boards- GERMANY, Mainz - BioNTech SE, a clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other serious diseases, today announced the completion of a USD 325 million Series B financing round, making it one of the largest single private funding rounds for a biotechnology company in European history.... => Read full post BioNTech Raises $325m Series B financing led by Fidelity Management & Research Company